Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Study of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

NCT03485495 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03485495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03485495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Study of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
April 12, 2018
Completion date
April 11, 2019
Enrollment
124 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral atherosclerosis